Rhia Ventures Statement on Supreme Court Mifepristone Decision
Rhia Ventures, a social impact organization that leverages the private sector to advance equitable reproductive and maternal health outcomes for women and other birthing people in the US, made this statement in response to the Supreme Court of the United States’ ruling on the legal dispute over the US Food & Drug Administration’s approval of the medication mifepristone.
“On Friday evening, April 21, the Supreme Court of the United States granted the stay request of the Department of Justice and Danco, the manufacturer of Mifeprifex, the commercial version of mifepristone. The decision by the Supreme Court to leave the FDA’s approval in place while the case proceeds allows mifepristone to remain on the market, for now.
The court’s decision preserves access to mifepristone as the Biden administration and Danco appeal a lower court ruling that would impose restrictions. Mifepristone remains approved for use through 10 weeks of pregnancy.
States where abortion is banned or subject to severe restrictions will continue to deny or reduce access to medication abortion. Far too many individuals in this country do not have access to comprehensive reproductive health care, and the Supreme Court’s latest decision does not change this.
As the legal fallout from the overturning of Roe v. Wade continues, this will undoubtedly create greater uncertainty and confusion among individuals and families seeking comprehensive reproductive health care. Those already marginalized by economic disparities, structural racism, and gender discrimination will continue to bear the brunt of the harm.
The gravity of our nation’s reproductive health equity crisis cannot be overstated. Bodily autonomy, freedom, and the ability for people to make their own decisions about their lives, families, and futures hang in the balance.
Rhia Ventures calls on all those in the business community who participate in the reproductive health care ecosystem to join us in our commitment to creating a world where every woman and birthing person can thrive with full autonomy over their reproductive and maternal health. We urge companies, investors, founders, board directors, and employees to use the opportunities and resources at their disposal to join the effort. While generations of advocates and activists have fought tirelessly for progress, the private sector has important levers to pull that have yet to be fully exercised. The time to act is now. We highlight resources below.”
-Erika Seth Davies, CEO
Resources
Rhia Ventures provides resources for employers seeking to implement better reproductive health care coverage policies in the post-Roe era.
If you are unsure of the status of abortion in your state, the Center for Reproductive Rights maintains an interactive map of abortion policies across the US.
The Repro Legal Helpline provides legal information or advice about US abortion laws and referrals to local resources.
The M&A Hotline is available to individuals who are self-managing miscarriage and abortion and in need of support from qualified medical professionals.
Information about Rhia Ventures, including contact information for media inquiries, is available here.
